Chinook Therapeutics Price on June 19, 2023

KDNYDelisted Stock  USD 39.25  0.20  0.51%   
If you're considering investing in Chinook Stock, it is important to understand the factors that can impact its price. As of today, the current price of Chinook Therapeutics stands at 39.25, as last reported on the 2nd of December, with the highest price reaching 39.37 and the lowest price hitting 38.95 during the day. We have found twenty-nine technical indicators for Chinook Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Chinook Therapeutics' Downside Deviation of 2.61, mean deviation of 2.8, and Risk Adjusted Performance of 0.1165 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Chinook Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
KDNY
Based on monthly moving average Chinook Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chinook Therapeutics by adding Chinook Therapeutics to a well-diversified portfolio.

Related Headline

Ventyx Biosciences Headline on 16th of June 2023

Filed transaction by Ventyx Biosciences Inc officer. General open market or private sale of non-derivative or derivative security

Chinook Therapeutics Valuation on June 19, 2023

It is possible to determine the worth of Chinook Therapeutics on a given historical date. On June 19, 2023 Chinook was worth 37.88 at the beginning of the trading date compared to the closed value of 38.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Chinook Therapeutics stock. Still, in general, we apply an absolute valuation method to find Chinook Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chinook Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Chinook Therapeutics' related companies.
 Open High Low Close Volume
  37.70    37.92    37.45    37.81    3,079,786  
06/16/2023
  37.88    38.13    37.67    38.04    2,857,839  
  38.04    38.10    37.83    37.94    1,366,801  
Backtest Chinook Therapeutics  |  Chinook Therapeutics History  |  Chinook Therapeutics Valuation   PreviousNext  
Open Value
37.88
38.04
Closing Value
37.88
Upside

Chinook Therapeutics Trading Date Momentum on June 19, 2023

On June 20 2023 Chinook Therapeutics was traded for  37.94  at the closing time. The top price for the day was 38.10  and the lowest listed price was  37.83 . The trading volume for the day was 1.4 M. The trading history from June 20, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.26% . The overall trading delta against the current closing price is 1.10% .

Chinook Therapeutics Fundamentals Correlations and Trends

By evaluating Chinook Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Chinook Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Chinook financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Chinook Therapeutics Stock history

Chinook Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Chinook is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Chinook Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Chinook Therapeutics stock prices may prove useful in developing a viable investing in Chinook Therapeutics
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington. Chinook Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 138 people.

Chinook Therapeutics Stock Technical Analysis

Chinook Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Chinook Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Chinook Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Chinook Therapeutics Period Price Range

Low
December 2, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Chinook Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Chinook Therapeutics December 2, 2024 Market Strength

Market strength indicators help investors to evaluate how Chinook Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Chinook Therapeutics shares will generate the highest return on investment. By undertsting and applying Chinook Therapeutics stock market strength indicators, traders can identify Chinook Therapeutics entry and exit signals to maximize returns

Chinook Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Chinook Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Chinook Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Chinook to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Chinook Stock

If you are still planning to invest in Chinook Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chinook Therapeutics' history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities